News & Updates

Patients with the coronavirus disease 2019 (COVID-19), even those genetically predisposed to the disease, are not at increased risk of developing atrial fibrillation, and vice versa, a study has found.

A recent study has recognized alanine and glutamine as new amino acids that appear to increase the risk of coronary artery disease (CAD) and reduce the hazard of ischaemic stroke, respectively.

Tolvaptan does not seem to be a cost-effective option for long-term treatment of chronic heart failure, reports a recent Japan study.

A recent study has shown that depression predicts the risk of developing heart failure (HF) with preserved ejection fraction (HFpEF) in late life, and the greater the symptoms, the higher the risk.